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ABSTRACT
Hemangioblastoma disseminated along leptomeninges from the solitary cranial lesion without 
von Hippel-Lindau (VHL) disease is a quite rare instance with 23 cases reported in 40 years. 
We add a new case and discuss these rare instances. A 55-year-old female underwent surgery for 
total removal of cerebellar hemangioblastoma. Twenty months later, magnetic resonance (MR) 
images of the spinal cord revealed a tumor compressing the thoracic cord at T3-4 level which 
was removed en bloc by emergent spinal surgery. However, paraplegia and bowel bladder 
dysfunction recurred 5 months after the spinal surgery. Spine MR images showed diffuse 
enhancement of subarachnoid space. Exploratory surgery disclosed that the enhanced lesion was 
disseminated hemangioblastoma. After whole spinal irradiation, she was transferred to a 
palliative care hospital. Even after complete removal, possibility of leptomeningeal 
dissemination demands continuous follow-up. The mechanism of seeding of hemangioblastoma 
remains unclear, but attention must be paid to avoid spreading tumor cells during surgery 
because all the disseminated cases had precedent cranial surgery.
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Hemangioblastomas are vascular-rich neo-
plasms, which typically arise in the cerebellum 
and account for 1.5-2.5% of all intracranial tu-
mors21). Approximately one fourth to one third of 
total hemangioblastomas are associated with von 
Hippel-Lindau (VHL) disease while the others are 
sporadic5,18,21). The first-line treatment for solitary 
hemangioblastomas is total resection as they are 
generally considered to be curable, non-metasta-
sizing tumors because of their low relapse 
rate3,7,11,15,19). However, 23 cases of leptomeningeal 
dissemination of hemangioblastomas from the soli-
tary cranial lesion without VHL disease have 
been reported since Mohan et al described the 
first case in 19761,4,8,10,12-14,16,17,22,26,27). We add a new 
case of leptomeningeal dissemination of heman-
gioblastomas without VHL disease and discuss 
these rare instances.
CASE REPORTS
A 55-year-old female presented with cerebellar 
hemangioblastoma manifested by headache (Fig. 
1). She had neither familial history nor clinical 
symptoms associated with VHL disease. She un-
derwent total removal of the tumor and ventriculo-
peritoneal shunt for idiopathic hydrocephalus. 
However, she presented with paraplegia 20 
months after the craniotomy. 
T1-weighted MR images with gadolinium-diethyl-
enetriaminepentacetate (Gd-DTPA) revealed a 
strongly enhanced tumor compressing the thoracic 
cord at T3-4 level (Fig. 2-a). We immediately re-
moved the tumor en bloc. Her symptoms temporarily 
recovered to be ambulant with the assistive braces. 
Histopathological diagnosis was typical benign he-
mangioblastoma except for high Ki-67 labeling in-
dex with a value of 30%. However, paraplegia and 
bowel bladder dysfunction recurred five months af-
ter the surgery.
T1-weighted MR images with Gd-DTPA showed 
that almost the entire subarachnoid space of the spi-
nal cord was strongly enhanced (Fig. 2-b). Exploratory 
surgery affirmed that the enhanced lesion was lepto-
meningeal dissemination of the hemangioblastoma 
(Fig. 3). Whole spinal irradiation at 45 Gy did not 
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DISCUSSION
Hemangioblastomas are generally considered be-
nign neoplasms and are classified as World Health 
Organization Grade I. Most of the recurrences after 
total resection of sporadic hemangioblastoma are 
usually observed at the primary site3,7,15,19). Although 
VHL disease can present with multifocal lesions, lep-
tomeningeal dissemination of hemangioblastoma 
from the solitary lesion is an extremely rare occur-
rence. A review of relevant medical literatures pub-
lished in the past 40 years including the present case 
identified 31 cases of leptomeningeal dissemination 
of hemangioblastoma: 24 associated with sporadic 
hemangioblastoma1,4,8,10,12-14,16,17,22,26,27) and 7 with 
VHL disease2,6,9,23-25,28).
The demographic and clinical characteristics of 
each sporadic case are detailed in Table 1. The age 
at the primary surgery of hemangioblastoma 
ranged from 4 to 71 years (mean: 44.9 years old) 
and included 13 males and 11 females. The primary 
lesion of all but one case were located in the poste-
rior cranial fossa. The latent period from the onset 
of primary hemangioblastoma to dissemination 
ranged from 7 months to 22 years (mean: 85.1 
months). This is longer than the prevailing concept. 
Surgery and/or cerebrospinal fluid cytology con-
firmed dissemination of hemangioblastoma in all 
cases. Although most of the cases received second-
ary palliative surgery and adjuvant therapy, as in 
our case, none of those therapies were effective. The 
mean survival after the diagnosis of dissemination 
in fatal cases ranged from 2 to 79 months (mean: 
25.7 months). Even in the survivors, most of the pa-
yield significant improvement of her symptoms. She 
was transferred to a palliative care hospital after the 
therapies.
Fig. 1. Gadolinium (Gd) -enhanced T1-weighted magnetic 
resonance (MR) image showing a strongly enhanced mass 
compressing the inferior vermis and medulla oblongata.
a　　　　　　　　　　　　b
Fig. 2
a)  T1-weighted MR image with Gd-diethylenetriaminepentacetate 
(Gd-DTPA) demonstrating a highly contrasted tumor 
compressing the thoracic cord at T3-4 level.
b)  T1-weighted MR image with Gd-DTPA revealing 
almost the entire subarachnoid space of the spinal 
cord is strongly enhanced.
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Fig. 3. Histological examination of tumor specimen 
stained with hematoxylin and eosin showing vacuolated 
stromal cells in rich capillary network. 
The stromal cells showed marked pleomorphic nuclei 
with degenerative atypia and hyperchromatic nuclei 
with scant lipid containing vacuoles. These findings 
indicate a histological diagnosis of hemangioblastoma.
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geal dissemination. Despite the occult mechanism 
of delayed dissemination, attention must be paid 
to avoid spreading tumor cells during surgery
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originally benign tumor may be associated with 
years of latency. The histopathological diagnosis 
made for each lesion in our case was typical heman-
gioblastoma without malignancy except for a high 
Ki-67 index. This high proliferative index value 
might have affected hasty dissemination. Further 
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CONCLUSION
We add a new case of leptomeningeal dissemina-
tion of hemangioblastoma. The review documented 
disseminated hemangioblastoma may occur after 
years of latency and have a dismal prognosis. Con-
tinuous follow-up longer than a decade might be 
necessary. Absence of dissemination in patients 
without craniotomy implies intraoperative spillage 
of tumor fragments as the etiology of leptomenin-
Table 1. Summary of the reported cases of leptomeningeal dissemination of hemangiomablastoma without VHL disease
Author Year No. Age Sex Primary site
Interval*
(months) Treatment**
Suvival***
(months) Seeding location
Mohan J et al.17) 1976 1 28 M Cerebellum 96 Surgery (B+S), RTx Dead (24) Pons, cervical spinal cord
2 39 M Cerebellum 168 Surgery (B+S), RTx Dead (3) Cervical spinal cord
Tohyama T et al.26) 1990 3 51 M Cerebellum 14 Surgery (B) Dead (2) Whole spine
Hande and Nagpal8) 1996 4 4 F Cerebellum 9 Surgery (B), RTx N/A Multiple brain, spinal cord
Weil RJ et al.27) 2002 5 43 F Cerebellum 84 Surgery (B+S), IFN-2α Dead (18) Suprasellar, pons, cerebellum, spinal cord
6 47 F Cerebellum 72 Surgery (B+S), RTx Dead (48) Cerebellum, medulla, spinal cord
7 34 M Cerebellum 2 Surgery (B+S), RTx Dead (37) Posterior fossa, spinal cord, optic chiasm
8 41 M Cerebellum 96 Surgery (B+S), RTx, RS Dead (24) Pons, medulla, spinalcord
Kato M et al.12) 2005 9 29 F Cerebellum 264 Surgery (B+S), RTx N/A Brain stem, cerebellum, spinal cord
Lightfoot NJ et al.16) 2007 10 71 F Foramen 
magnum
60 Surgery (B+S), RTx N/A Brain stem, spinal cord
Kim HR et al.13) 2009 11 41 M Cerebellum 120 Surgery (B+S), RTx, RS Dead (12) Suprasella, medulla, spinal cord
Reyes-Botero G et al.22) 2012 12 31 M Cerebellum 60 Surgery (B), Sunitinib Dead (15) Cerebellum, brain stem, whole spine
Chung SY et al.4) 2014 13 59 M Cerebellum 60 Surgery (B+S), RS N/A Cerebellum, brain stem, multiple spine
Akimoto J et al.1) 2014 14 45 F Cerebellum 91 Surgery (B+S), RTx, RS Dead (29) Multiple brain and spine
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18 36 M Cerebellum 204 Surgery (B+S) Alive (26) Pons, cerebellum, spinal cord
19 45 M Cerebellum 39 Surgery (B) Alive (46) Medulla, spinal cord
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cisterna magna
21 54 F Cerebellum 50 Surgery (B), RTx Alive (22) Basal cistern, premedullary cistern, 
tentorium
22 48 M Spine 132 Surgery (S) Alive (67) CPA, frontal base, middle cranial fossa
23 51 M Cerebellum 64 Surgery (S) Dead (5) Pons, midbrain, insula, parietal lobe
Present case 2016 24 55 F Cerebellum 24 Surgery (B+S), RTx Alive (5) Whole spine
Mean age at initial surgery (years old, range) 44.9 (4-71)
Mean time to dissemination (months, range) 85.1 (9-264)
Mean survival in fatal cases (months, range) 25.7 (2-79)
Abbreviations: VHL=Von Hippel-Lindau, B=brain, S=spine, RTx=radiotherapy, RS=radiosurgery, CPA=cerebellopontine angle
Interval*: time to dissemination after the initial surgery, Treatment**: treatment for primary and disseminated lesion
Survival***: survival after the diagnosis of dissemination
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